Seroprevalence and associated factors of maternal cytomegalovirus in Southern Ethiopia

Introduction

Cytomegalovirus (CMV) is the most common infection during pregnancy that poses the risk of congenital CMV infections (cCMV) worldwide.(1) In immunocompetent hosts, primary CMV infection may be asymptomatic or may cause mild self-limiting disease with fever, headaches, and myalgia and after primary infection the virus remains latent. Latency following a primary infection may relapse by periodic reactivations that give rise to recurrent infections later in life when the body immunity is suppressed.(2)

CMV infection or reactivation during pregnancy is mostly asymptomatic, however may lead to fetal infection and cCMV syndromes.(3) Congenital CMV infection of the fetus of mothers having pre-existing anti-CMV antibodies is also possible due to risk of reactivation or reinfection with a different strain of CMV during pregnancy.(4) Therefore unlike previous perception the high maternal CMV seroprevalence in developing countries like Ethiopia does not eliminate the threat of cCMV infection of the newborn. Worldwide cCMV following nonprimary maternal infections is more common in individuals of lower socioeconomic background.(5)

So far studies have shown maternal seropositivity rates of previous infection ranging from low (50 to 70%) in developed countries, to high (>□70%) in developing countries.(1) Presently, data on the prevalence of maternal CMV and associated risk factors are scanty in Ethiopia. The only available study conducted in Ethiopia had reported the prevalence of 15.5% for IgM and 88.6% for CMV IgG.(6)

In Africa the highest prevalence of CMV IgG was estimated ranging from 72 – 97.5% (7, 8) and of CMV IgM antibodies ranging from 0-15.5%.(9) However, for several reasons CMV infection among pregnant women in Africa have been overlooked.(10) One of the main reasons for +inattention is the perception that being infected in early childhood endures immunity for subsequent infection, so maternal reactivation or reinfection during pregnancy is unlikely to cause severe congenital infection.(11) However, in pregnant women the immune system is somehow suppressed. So ignoring maternal CMV and the subsequent effect of cCMV infection in Africa is short-sighted; furthermore, the possible confounding effects of HIV infection, malnutrition, tuberculosis, and a general higher disease burden of the continent must be taken into account.(12)

The objective of the study was to assess the seroprevalence of CMV among pregnant women and determine associated factors in Southern Ethiopia. Information about maternal the prevalence of CMV and associated risk factors is almost absent in Ethiopia and this study was the first in the southern region. We hope the study will attract health care professional attention and improve antenatal care in this domain. In the meantime it will generate awareness to the community, mainly pregnant women, regarding the consequence of CMV during pregnancy in Ethiopia.

Methodology

Results

Six hundred pregnant women were assessed for seroprevalence of CMV. The mean of maternal age was 27.0 ± (SD) 5.2, with a ranging between 17 and 41. More than one-third of the study participant were under the age of 25. About one-fourth of the women were Primigravida. Out of the 600 participant 84 (14%) were currently unmarried, 475 (79.2%) were residing in urban setting, 377 (62%) were above or at secondary level of education. Forty-eight (8%) of the newborns were under-weighted (<2.5 Kg), and 64 (10%) of the births were preterm. Regarding STIs test result, 51 (14.6%) pregnant women were tested positive for any of curable STIs (Table 1).

In this study, around 96% of mothers had no knowledge of congenitally transmitted infection or the associated risks in pregnancy and about 9% of them had previous adverse pregnancy outcome. The chi-squire analysis shown that, seropositivity for CMV IgM significantly associated (p<0.05) with marital status, gestational age, having nursery school baby in the household, sharing a cup with children and having any of detected curable STIs. However, there was no significant association with birth weight, gravidity and having previous adverse pregnancy outcome i.e. preterm birth, stillbirths and early neonatal death (Table 1).

Discussion

In this study an overall 8.2% CMV IgM and 88.7% seroprevalence of CMV IgG were detected among pregnant women in southern Ethiopia. The associated factors of seropositivity were age, marital status, the presence of a curable STIs and sharing a cup with children. A statistically significant association was also observed between CMV seropositivity and preterm delivery.

The reported seropositivity of 88.6% CMV IgG in this study was comparable to a previous report of 88.5% h in central Ethiopia but a substantially higher rate (15.5%) of CMV IgM was detected in this study.(6) Seropositivity of CMV IgG in our study was in line with a review done in Africa, with ranges from 60% to 100%.(9) Seropositivity rates of 77.3% for IgG and 8.1% for IgM in Kenya,(7) 93% for IgG and 11.1% for IgM in Nigeria,(13) 94% for IgG and 8.5% for IgM in Tanzania(14) were comparable to our finding.

In our study seroprevalence of CMV IgM is in concordance with several African studies.(7, 13-15) However, our rate was higher when compared to 0.4% in Tanzania,(16) 2.5% in Sudan,(17), and 7% in Egypt.(18) In the absence of maternal screening this high rate is alarming for policy makers. By far developed countries pregnant women are screened for CMV because of the consequence for the fetus and newborn.(19, 20) However, in most developing countries including Ethiopia, maternal CMV still lack awareness, overlooked and not diagnosed at least for pregnant women.(21) The high rate of positive CMV IgM may not only reflect primary infection but might also be attributed to reinfection or reactivation of CMV during pregnancy. So the reported high seropositivity in this study point to the existing negligence and the need to start screening to detect pregnant women at risk for congenital transmission of CMV.

In this study, elder age has significant association with seroprevalence. The same finding was reported in Sudan,(17) Kenya,(22), and Tanzania.(16) In addition a large scale study in London also reported that seropositivity increases with increasing age.(23) But, in a study in Egypt(18) and in Nigeria(24) age had no association with maternal CMV infection. The highest seroprevalence with age may indicate the more exposure of elders than youngsters or might be the existence of previous infection which can probably reactivated in the current pregnancy.

On the other hand, significant association of seroprevalence with having nursery schooled children among household was observed. For pregnant women the predictable source of CMV infection is young children mainly exposure to nursery schooled children.(25) Children easily get infected in school and frequently shed CMV in their saliva or urine for many years continuously where spreads readily in preschool setting.(26) This places seronegative pregnant women who have a young child in the home or in day care at increased risk of seroconversion.(27, 28) Susceptibility to acquisition of CMV infection is high possibly through the direct contact with contagious secretions from their own children essentially in situation of poor hygienic practice like in Ethiopia.(23)

Among candidate predictors for maternal CMV seropositivity, occupation like being health care worker, or child day care worker; being multigravida, lower educational level and having other children at home were not detected. However, significant association with women who delivered preterm was reported. Although, preterm delivery might be due to the effect of maternal CMV infection we can not to say the risk factor as there are a lot of other confounding factors for preterm.(29)

Likewise, seropositivity was found to be significantly associated with STIs detected at delivery and currently being unmarried. Mothers who were positive for any of curable STIs had a four-time CMV seropositivity. It is also reported that STIs including CMV is more common in unmarried pregnant women.(23, 25, 30) Although cytomegalovirus is a virus that is transmitted through many body fluids, sexual transmission from a seropositive male partner is an additional established route by which women may be infected with CMV.(31) Indeed, it is somehow expected that sexual transmission is also responsible for reinfection of seropositive mothers with different virus strains in high-seroprevalence populations.(32)

The limitations of the present study are that we lack differentiation of CMV IgM positives of either primary or secondary (reinfection or reactivation) since we collected samples at the end of pregnancy and avidity test will not suitable. Moreover, it was a hospital-based study and not representative of all pregnant mothers in the locality since a significant portion of mothers may not deliver in the hospital. We lack also appropriate risk factors assessment tool as we mainly focused on seroprevalence and nature of the enrolled participant (time of labour), hence more representative large scale survey is needed to identify possible risk factors prospectively.

Conclusion

In the present study, we documented a high rate of CMV seroprevalence among pregnant women in southern Ethiopia. The presence of a curable STIs, elder age, unmarried women, and having nursery schooled children have a significant association with seropositivity. Given that there is no existing CMV diagnostic facility, special attention should be designed for pregnant women in parallel to the existing antenatal care service. Besides, training health care professionals will support awareness conception for pregnant women concerning the sequels of CMV infection during pregnancy.

Author Contributions

MH and EP contributed to the study design and conceptualisation. MH carried out the laboratory work. MH, EL, ZM and EP performed the statistical analysis and interpretation. All authors provided critical review and contributed to the write-up and approved the final version of the manuscript. MH had final responsibility to submit for publication. All authors read and amended drafts of the paper and approved the final version.

Funding

No funding was obtained. But A PhD Scholarship supported by the research from the Belgian Development Cooperation through the VLIR-UOS network program (University collaboration for better health in Ethiopia (UCBHE).

Competing interests

no competing interest

Patient consent

Obtained. All participants provided written, informed consent for study participation.

Ethics approval

Ethical approval from all of the appropriate institutional review boards was obtained. The ethics review committee of Hawassa University (CMHS/283/2012), Jimma University (IHRPGD/458/2020), National Health Research Ethics Review Committee (SRA/14.1/ 144483/2020) Ethiopia, and Ghent University (PA2019-038/BC-08458) Belgium, approved the study.

Data sharing statement

No additional data are available.